McDermott Will & Schulte advises Cadence as health regulatory counsel in $100 million Series C led by Spark Capital

Global law firm McDermott Will & Schulte advised Cadence, a care management and remote patient monitoring company utilizing AI to manage chronic care for older adults, as health regulatory counsel in connection with its $100 million Series C financing led by Spark Capital. The investment values Cadence at $1.23 billion. Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures, Memorial Hermann, and Duke Health also participated in the fundraising.

Cadence announced that the new investment will help scale its clinical AI agents and that it will focus on expansion across new health systems, advancement of Cadence’s AI agents and growth in value-based care models. Cadence currently treats more than 100,000 patients at 21 health systems.

The McDermott team was led by Caroline Reignley with invaluable support from Patrick Zanayed and Grayson Dimick. Jed Spielman, Lisa Mazur and Charlie Buck are the relationship partners for Cadence.

Read the press release here.

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,700+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.